[ Price : $8.95]
Universities Allied for Essential Medicines is calling on FDA to step up enforcement of the clinical trial reporting requirements ...[ Price : $8.95]
FDA issues Gasc Industrial Corp. in Gurabo, Puerto Rico, a Warning Letter after inspecting its manufacturing facility and citing s...[ Price : $8.95]
Merck says it is discontinuing the Phase 3 KEYNOTE-641 trial evaluating Keytruda (pembrolizumab) in combination with enzalutamide ...[ Price : $8.95]
FDAs Vaccines and Related Biological Products Advisory Committee votes to recommend approval of Pfizers respiratory syncytial viru...[ Price : $8.95]
FDA seeks comments on a just-released discussion paper on artificial intelligence areas for use in drug manufacturing and policy d...[ Price : $8.95]
Federal Register notice: FDA denies a hearing request from Richard M. Fleming seeking to terminate his 2018 debarment order.[ Price : $8.95]
FDA approves a Reata Pharmaceuticals NDA for Skyclarys (omaveloxolone) as the first treatment for Friedreichs ataxia, a rare degen...[ Price : $8.95]
CDER Office of Neuroscience director Billy Dunn, a top figure in FDAs controversial approval of Biogens Alzheimers drug Aduhelm, a...